Download presentation
Presentation is loading. Please wait.
Published byBarrie George Modified over 8 years ago
1
5. Common and rare alleles Mutation means 1. the process by which a gene undergoes a structural change, 2. a modified gene resulting from mutation Mutations: -gene mutations -„point“ mutation – only one nucleotide qualitative change -in regulatory sequences quantitative change -compound mutations -chromosomal mutations -numerical -structural
2
Fig. 1: Destiny of gene mutations (alleles) in populations. How common and rare alleles originate 1
3
Fig.2 2
4
A fresh allele (point mutation) is subject to changes in its relative frequency according to the circumstances (its adaptive value in the environment). A polymorphism may be totally neutral, slightly different or (rarely) very different. Rare alleles may produce serious diseases easily 4000 Mendelean conditions, 1/3 of proteins polymorphic, virtually any locus polymorphic regarding DNA
5
6. Genic variability of the hemoglobin molecule 6.1 Gene determination and biochemistry Fig. 3 Hemoglobin molecule 3
6
Fig. 4 Genetic detemination of human hemoglobins
7
Fig. 5 Disposition of Hb genes along chromosomes Different Hb genes resulted from gene duplications. 1 and 2 the same polypeptide 5
8
Several hundreds, the majority of them rare Fig. 6 6.2 Point mutations of Hb molecule
9
Hereditary methemoglobinemias Fig. 7 Several alleles – point mutations in the vicinity of heme group. Fe3+ bound to the inappropriate AA methemoglobin reductase unable to reduce it (Mutations of methemoglobin reductase the same „distant“ phenotype) Neutral Deleterious: doubtless when heterozygotes are diseased, problematic when heterozygotes are not manifestly ill (recessive mutations)
10
7
11
Unstable hemoglobins Mutation conformation change instability of the molecule chronic hemolytic anemia. RBC: Heinz bodies, stiffness life span Changed affinity to oxygen Enhanced affinity shift of the dissociation curve to the left delivering of oxygen to tissues erythrocytosis Lowered affinity mild anemia Small stereochemical changes in a molecule drastic changes in function
12
8 Fig. 8 Some point mutations in the Hb -chain
13
Hb polymorphisms Sickle cell anemia (HbS) -chain, position 6, Glu Val SCA = homozygosity for HbS - life span, virtually no descendants Sickle cell trait heterozygosity for HbS - sickle RBC in hypoxic conditions Oxygen affinity Hb oxigenation gelling of Hb sickling of RBC and lowered deformability obturation of capillaries local ischemia etc (Fig. 9 Other polymorphisms: HbC, HbE, HbD, HbK, HbO, HbJ Tongariki – mild problems
14
9
15
Adaptive significance of Hb polymorphisms Dozens of % in (sub)tropical regions, about 5% in the border localities Strong directed selection against HbS its maintaining cannot be caused by drift Plasmodium falciparum stabilizing selection and balanced polymorphism ( resistence in small children, blocking of penetration through placenta fertility of heterozygotic women) Other polymorphisms – only probability of enhanced resistance
16
Compound mutations: Hb Harlem Deletions and additions Constant Spring Hb: mutation in a stop codon additional 31 AA in the -chain The same effect as gene deletion Le Pore Hb: mixed chains / and / . Cause: unequal crossing over in meiosis 6.3 Other types of Hb mutations
17
6.4 Thalassemias
18
10 Fig 10 Mutations determining the extent to which the polypeptide chains are formed
19
-thalassemia interference with -chain production. Thalassemia major = Cooley´s anemia: Homozygosity for alleles of -chain gene grossly abnormal RBC, unused -chains precipitate RBC destruction Thalassemia minor: Heterozygotes, many pathological alleles heterogeneity of the disease (between homozygotes and norm)
20
Etiology of -thalassemias: - intron mutations - new splicing sequencies GT, AT shortening of the transcript - cancelling of splicing sequencies or destruction of the polyadenylation sequence prolongation of the transcript - mutation of a stop codon chain elongation - mutation of a starting codon or destruction of a promoter complete deletion of the -gene -thalassemia interference with -chain production Etiology: -chain gene deletion, 1 – 4
21
Majority of point mutations are rare, from neutral to grossly pathologic In non-malaric regions: a single „normal“ Hb - HbA1 (possibly HbA2 with -chains). These alleles are fixed and optimal (neutral) In malaric regions: a whole array of polymorphisms (balanced polymorphisms) maintained by stabilizing selection Nearly neutral polymorphisms – a common situation in many genes. Disadvantageous polymorphic alleles must be compensated for, typically by heterozygote advantage 6.5 A survey of adaptive (health) significance of Hb mutations
22
Izoenzymes: in most cases no known functional explanation of the existence of variants Pentose shunt pathway NADPH reduced glutathione protection of Hb against oxidation Fig.11 Deficiency of the G6PD hemolytic crises after ingestion of Vicia fava (bean), anti-malarials, sulphonamides etc. Fig.12 6.6 Glucose-6-phosphate dehydrogenase G6PD polymorphisms
23
11
24
A - acute hemolytic Anemia (AHA) Favism Drugs Activity 0.16 T Africa 0.20 2 mutat. A + asymptom. Activity 0.84 Africa 0.25 B – (mediter.) AHA, favism Act. 0.00 – 0.07 T Mediter. 0.15 – 0.20 Kurdistan Jews 0.55 B + “normal” G6PD 12
25
Gd(A+) – 20% in Africa slightly reduced activity Gd(A-) – 20% in Africa 8-20% activity drug sensitivity Mediterranean (Gd(B-)) – 15 to 20% in Greece, Sardinia, Middle East, India activity less than 7% of norm In all forms the enzyme is unstable (e.g., T1/2 = 13 days instead of 62 days)
26
Rare diseases - one major gene and allele - Mendelean heredity - severe, in childhood - rare - environmental influences weak Common diseases - several genes, only slightly deleterious alleles - only enhanced disposition in families - chronic, in adults and elderly - common (mostly „civilization“ diseases) - environmental conditions decisive Fig. 13 Genetic architecture of essential hypertension 6.7. Common and rare diseases
27
13
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.